These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 34400183)
1. Inhibition of N-Nitrosamine Formation in Drug Products: A Model Study. Nanda KK; Tignor S; Clancy J; Marota MJ; Allain LR; D'Addio SM J Pharm Sci; 2021 Dec; 110(12):3773-3775. PubMed ID: 34400183 [TBL] [Abstract][Full Text] [Related]
2. A Nitrite Excipient Database: A Useful Tool to Support N-Nitrosamine Risk Assessments for Drug Products. Boetzel R; Schlingemann J; Hickert S; Korn C; Kocks G; Luck B; Blom G; Harrison M; François M; Allain L; Wu Y; Bousraf Y J Pharm Sci; 2023 Jun; 112(6):1615-1624. PubMed ID: 35500671 [TBL] [Abstract][Full Text] [Related]
3. Bumetanide as a Model NDSRI Substrate: N-nitrosobumetanide Impurity Formation and its Inhibition in Bumetanide Tablets. Shakleya D; Asmelash B; Alayoubi A; Abrigo N; Mohammad A; Wang J; Zhang J; Yang J; Marzan TA; Li D; Shaklah M; Alsharif FM; Desai S; Faustino PJ; Ashraf M; O'Connor T; Vera M; Raw A; Sayeed VA; Keire D J Pharm Sci; 2023 Dec; 112(12):3075-3087. PubMed ID: 37364772 [TBL] [Abstract][Full Text] [Related]
9. Studies on nitrosamine formation by the interaction between drugs and nitrite. I. Measurement of the amount of nitrosamine formed in rat and guinea pig stomachs. Kawanishi T; Ohno Y; Takahashi A; Ishiwata H; Tanimura A; Kasuya Y; Omori Y J Toxicol Sci; 1981 Nov; 6(4):261-70. PubMed ID: 7338958 [TBL] [Abstract][Full Text] [Related]
10. Parts per billion of nitrite in microcrystalline cellulose by ion chromatography mass spectrometry with isotope labeled internal standard. Zhu K; Kerry M; Serr B; Mintert M J Pharm Biomed Anal; 2023 Oct; 235():115648. PubMed ID: 37611458 [TBL] [Abstract][Full Text] [Related]
11. Influence of amine structural characteristics on N-nitrosamine formation potential relevant to postcombustion CO2 capture systems. Dai N; Mitch WA Environ Sci Technol; 2013 Nov; 47(22):13175-83. PubMed ID: 24138561 [TBL] [Abstract][Full Text] [Related]
12. Nitroso Impurities in Drug Products: An Overview of Risk Assessment, Regulatory Milieu, and Control Strategy. Charoo NA; Dharani S; Khan MA; Rahman Z AAPS PharmSciTech; 2023 Feb; 24(2):60. PubMed ID: 36759424 [TBL] [Abstract][Full Text] [Related]
14. Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis. Hecht SS Proc Soc Exp Biol Med; 1997 Nov; 216(2):181-91. PubMed ID: 9349687 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of nitrosamine formation by ascorbic acid. Tannenbaum SR; Wishnok JS; Leaf CD Am J Clin Nutr; 1991 Jan; 53(1 Suppl):247S-250S. PubMed ID: 1985394 [TBL] [Abstract][Full Text] [Related]
16. Nitrosamine Impurities in Pharmaceuticals: An Empirical Review of their Detection, Mechanisms, and Regulatory Approaches. Bhirud D; Agrawal G; Shah H; Patel A; Palkar MB; Bhattacharya S; Prajapati BG Curr Top Med Chem; 2024; 24(6):503-522. PubMed ID: 38321910 [TBL] [Abstract][Full Text] [Related]
17. Investigation of the Formaldehyde-Catalyzed NNitrosation of Dialkyl Amines: An Automated Experimental and Kinetic Modelling Study Using Dibutylamine. Diab S; Ferrini P; Dominey AP; Whiting MP; Wickens JR; Ashworth IW; Rainey TJ J Pharm Sci; 2024 Jun; 113(6):1624-1635. PubMed ID: 38307493 [TBL] [Abstract][Full Text] [Related]
18. A comprehensive review of sources of nitrosamine contamination of pharmaceutical substances and products. Akkaraju H; Tatia R; Mane SS; Khade AB; Dengale SJ Regul Toxicol Pharmacol; 2023 Mar; 139():105355. PubMed ID: 36792049 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the protective effect of ascorbic acid on nitrite- and nitrosamine-induced cytotoxicity and genotoxicity in human hepatoma line. Erkekoglu P; Baydar T Toxicol Mech Methods; 2010 Feb; 20(2):45-52. PubMed ID: 20100056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]